Echelon Biosciences Inc.
SEARCH






ASSAYS AND REAGENTS FOR DRUG DISCOVERY IN LIPID SIGNALING PATHWAYS
FORUMS
PRODUCT CATEGORIES
Antibodies and Lipid Recognition Proteins
Assay Service
Assays
Enzymes
Heme Pathway
Inhibitors
Inositol Phosphates
Intracellular Lipid Delivery Systems
Isoprenoids
Lipid-Protein Interaction Tools
Lipids
Lysophospholipid Products
MEP Pathway intermediates
Phosphoinositide Reagents and Derivatives
Phospholipase Substrates
Protein Kinases & Phosphatases
Sphingolipid Products
PURCHASE ASSISTANCE
Order Status
My Quotation
My Account
DISTRIBUTORS
TECHNICAL SUPPORT / FAQ
NEWS
TECHNICAL DATA SHEETS &     PROTOCOLS
PUBLICATIONS
BROWSE BY PATHWAY
FEEDBACK
SUBMIT PRODUCT IDEAS
Direct:801-588-0455
Fax:801-588-0497
       Category :   Phospholipase Substrates : FS-3 (lysoPLD / Autotaxin substrate)



Click to enlarge

Product Name

Catalog Number

Unit Price


FS-3 (LysoPLD / Autotaxin substrate),

Echelon's new fluorogenic lysoPLD substrate (L-2000) is a doubly labeled analog wherin the fluorophore is quenched through intramolecular energy transfer. Cleavage of substrate by lysoPLD produces an increase in fluorescence.

Lysophospholipase, also known as Autotaxin (ATX), cleaves choline from lysophosphatidylcholine forming lysophosphatidic acid (LPA), a potent mitogen that as been implicated in the pathophysiology of ovarian cancer. LysoPLD/ATX has been demonstrated to increase cell motility, neovascularization, proliferation, and aggressiveness of tumors and is upregulated in numerous cancer lineages (non-small cell lung , glioma, mammary carcinoma, renal cell carcinoma, hepatocellular carcinoma). Modulation of lysoPLD activity through small-molecules is a currently underexplored target, but one with high potential for novel cancer therapeutics.
Mol. Wt. :
—1286.4
Mol. Formula :
—C64H84N7O19P
Solubility :
—5 mg / mL in H2O or MeOH
Featured in Publication :
Organic Letters, May 2006
J. Biol. Chem, Aug 2006
Bioorganic & Medicinal Chemistry , Nov 2007
 
Additional Informaiton
  --
L-2000